Login Register Cart 0
Generic placeholder image

Recent Advances in Anti-Infective Drug Discovery

Editor-in-Chief

ISSN (Print): 2772-4344
ISSN (Online): 2772-4352

Back
Journal Home About Journal Editorial Board Current Issue Volumes/Issues
Subscribe
Mini-Review Article

Medicinal Plants as Natural Anti-Parasitic Agents Against Blastocystis Species

Author(s): Nagwa Mostafa El-Sayed* and Nagham Gamal Masoud

Volume 18, Issue 1, 2023

Published on: 15 December, 2022

Page: [2 - 15] Pages: 14

DOI: 10.2174/2772434418666221124123445

Price: $65

Abstract

Background: Blastocystis species (sp.) are enteric parasites that live in both humans' and animals' gastrointestinal tracts. Blastocystis hominis (B. hominis) is the recognizable human isolates in clinical and diagnostic specimens. Human infection occurs via the oro-fecal route, particularly in developing areas due to the lack of sanitation and hygienic facilities. B. hominis can exist in the large intestine for weeks to years until treated appropriately. Metronidazole is the drug of choice for the treatment of Blastocystis infection. However, it induces intolerable side effects and has been shown to have teratogenic and carcinogenic potential. Several medicinal plant extracts have been experimentally tested against Blastocystis infection in comparison to currently available treatments.

Objective: Based on in vitro and in vivo studies, this article reviewed anti-Blastocystis activity of some medicinal plants.

Methods: To conduct the research for this review, Google Scholar and PubMed were the primary search engines used to find relevant literature. A total of 19 published in vitro and in vivo studies were evaluated to identify the anti-Blastocystis effects of various medicinal plants.

Results: Multiplication of Blastocystis parasites as well as nucleic acids and protein synthesis, all be inhibited by extracts from different medicinal plants. These natural agents have been shown to be both safe and effective when compared to the existing treatment options.

Conclusion: Different medicinal plants can combat Blastocystis infection and could be a good substitute for metronidazole and other synthetic treatments.

« Previous Next »
Graphical Abstract

[1]
Wawrzyniak I, Poirier P, Viscogliosi E, et al. Blastocystis, an unrecognized parasite: An overview of pathogenesis and diagnosis. Ther Adv Infect Dis 2013; 1(5): 167-78.
[http://dx.doi.org/10.1177/2049936113504754] [PMID: 25165551]
[2]
Dogruman-Al F, Kustimur S, Yoshikawa H, et al. Blastocystis subtypes in irritable bowel syndrome and inflammatory bowel disease in Ankara, Turkey. Mem Inst Oswaldo Cruz 2009; 104(5): 724-7.
[http://dx.doi.org/10.1590/S0074-02762009000500011] [PMID: 19820833]
[3]
Pavanelli MF, Kaneshima EN, Uda CF, Colli CM, Falavigna-Guilherm AL, Gomes ML. Pathogenicity of Blastocystis sp. to the gastrointestinal tract of mice: Relationship between inoculum size and period of infection. Rev Inst Med Trop São Paulo 2015; 57(6): 467-72.
[http://dx.doi.org/10.1590/S0036-46652015000600002] [PMID: 27049699]
[4]
Tan KSW. New insights on classification, identification, and clinical relevance of Blastocystis spp. Clin Microbiol Rev 2008; 21(4): 639-65.
[http://dx.doi.org/10.1128/CMR.00022-08] [PMID: 18854485]
[5]
Stensvold CR, Clark CG. Current status of Blastocystis: A personal view. Parasitol Int 2016; 65(6): 763-71.
[http://dx.doi.org/10.1016/j.parint.2016.05.015] [PMID: 27247124]
[6]
Stensvold CR, Arendrup MC, Jespersgaard C, Mølbak K, Nielsen HV. Detecting Blastocystis using parasitologic and DNA-based methods: A comparative study. Diagn Microbiol Infect Dis 2007; 59(3): 303-7.
[http://dx.doi.org/10.1016/j.diagmicrobio.2007.06.003] [PMID: 17913433]
[7]
Jones MS, Whipps CM, Ganac RD, Hudson NR, Boroom K. Association of Blastocystis subtype 3 and 1 with patients from an Oregon community presenting with chronic gastrointestinal illness. Parasitol Res 2009; 104(2): 341-5.
[http://dx.doi.org/10.1007/s00436-008-1198-7] [PMID: 18923844]
[8]
Dogruman-Al F, Dagci H, Yoshikawa H, Kurt Ö, Demirel M. A possible link between subtype 2 and asymptomatic infections of Blastocystis hominis. Parasitol Res 2008; 103(3): 685-9.
[http://dx.doi.org/10.1007/s00436-008-1031-3] [PMID: 18523804]
[9]
Hussein EM, Hussein AM, Eida MM, Atwa MM. Pathophysiological variability of different genotypes of human Blastocystis hominis Egyptian isolates in experimentally infected rats. Parasitol Res 2008; 102(5): 853-60.
[http://dx.doi.org/10.1007/s00436-007-0833-z] [PMID: 18193282]
[10]
Chandramathi S, Suresh K, Shuba S, Mahmood A, Kuppusamy UR. High levels of oxidative stress in rats infected with Blastocystis hominis. Parasitology 2010; 137(4): 605-11.
[http://dx.doi.org/10.1017/S0031182009991351] [PMID: 19961647]
[11]
Yakoob J, Jafri W, Beg MA, et al. Irritable bowel syndrome: Is it associated with genotypes of Blastocystis hominis. Parasitol Res 2010; 106(5): 1033-8.
[http://dx.doi.org/10.1007/s00436-010-1761-x] [PMID: 20177906]
[12]
Fouad SA, Basyoni MMA, Fahmy RA, Kobaisi MH. The pathogenic role of different Blastocystis hominis genotypes isolated from patients with irritable bowel syndrome. Arab J Gastroenterol 2011; 12(4): 194-200.
[http://dx.doi.org/10.1016/j.ajg.2011.11.005] [PMID: 22305500]
[13]
Tejera B, Grados D, Martinez-Morillo M, Roure S. Reactive arthritis caused by Blastocystis hominis. Reumatol Clin 2012; 8(1): 50-1.
[http://dx.doi.org/10.1016/j.reuma.2011.07.008] [PMID: 22178255]
[14]
Vogelberg C, Stensvold CR, Monecke S, et al. Blastocystis sp. subtype 2 detection during recurrence of gastrointestinal and urticarial symptoms. Parasitol Int 2010; 59(3): 469-71.
[http://dx.doi.org/10.1016/j.parint.2010.03.009] [PMID: 20363362]
[15]
Zuel-Fakkar NM, Abdel Hameed DM, Hassanin OM. Study of Blastocystis hominis isolates in urticaria: A case-control study. Clin Exp Dermatol 2011; 36(8): 908-10.
[http://dx.doi.org/10.1111/j.1365-2230.2011.04127.x] [PMID: 21790724]
[16]
Valsecchi R, Leghissa P, Greco V. Cutaneous lesions in Blastocystis hominis infection. Acta Derm Venereol 2004; 84(4): 322-3.
[http://dx.doi.org/10.1080/00015550410025949] [PMID: 15339085]
[17]
El-Sayed NM, Abdel-Wahab MM. Detection of Blastocystis in stool specimens using parasitological methods and commercial antigen detection enzyme-linked immunosorbent assay: A comparative study. J Med Sci 2011; 32(1): 327-38.
[18]
Dinleyici EC, Eren M, Dogan N, Reyhanioglu S, Yargic ZA, Vandenplas Y. Clinical efficacy of Saccharomyces boulardii or metronidazole in symptomatic children with Blastocystis hominis infection. Parasitol Res 2011; 108(3): 541-5.
[http://dx.doi.org/10.1007/s00436-010-2095-4] [PMID: 20922415]
[19]
Coyle CM, Varughese J, Weiss LM, Tanowitz HB. Blastocystis: To treat or not to treat. Clin Infect Dis 2012; 54(1): 105-10.
[http://dx.doi.org/10.1093/cid/cir810] [PMID: 22075794]
[20]
Vassalos CM, Spanakos G, Vassalou E, Papadopoulou C, Vakalis N. Differences in clinical significance and morphologic features of Blastocystis sp subtype 3. Am J Clin Pathol 2010; 133(2): 251-8.
[http://dx.doi.org/10.1309/AJCPDOWQSL6E8DMN] [PMID: 20093234]
[21]
Nasirudeen AMA, Hian YE, Singh M, Tan KSW. Metronidazole induces programmed cell death in the protozoan parasite Blastocystis hominis. Microbiology 2004; 150(1): 33-43.
[http://dx.doi.org/10.1099/mic.0.26496-0] [PMID: 14702395]
[22]
Haresh K, Suresh K, Anuar AK, Saminathan S. Isolate resistance of Blastocystis hominis to metronidazole. Trop Med Int Health 1999; 4(4): 274-7.
[http://dx.doi.org/10.1046/j.1365-3156.1999.00398.x] [PMID: 10357863]
[23]
Mirza H, Teo JDW, Upcroft J, Tan KSW. A rapid, high-throughput viability assay for Blastocystis spp. reveals metronidazole resistance and extensive subtype-dependent variations in drug susceptibilities. Antimicrob Agents Chemother 2011; 55(2): 637-48.
[http://dx.doi.org/10.1128/AAC.00900-10] [PMID: 21098237]
[24]
Upcroft P, Upcroft JA. Drug targets and mechanisms of resistance in the anaerobic protozoa. Clin Microbiol Rev 2001; 14(1): 150-64.
[http://dx.doi.org/10.1128/CMR.14.1.150-164.2001] [PMID: 11148007]
[25]
Ok ÜZ. Girginkardeşler N, Balcioğlu C, Ertan P, Pirildar T, Kilimcioğlu AA. Effect of trimethoprim-sulfamethaxazole in Blastocystis hominis infection. Am J Gastroenterol 1999; 94(11): 3245-7.
[http://dx.doi.org/10.1111/j.1572-0241.1999.01529.x] [PMID: 10566723]
[26]
Ertuğ, S, Dost T, Ertabaklar H, Gültekin B. The effect of trimethoprim-sulfamethoxazole in Blastocystis hominis infection. Turkiye Parazitol Derg 2009; 33(4): 270-2.
[PMID: 20101575]
[27]
Moghaddam DD, Ghadirian E, Azami M. Blastocystis hominis and the evaluation of efficacy of metronidazole and trimethoprim/sulfamethoxazole. Parasitol Res 2005; 96(4): 273-5.
[http://dx.doi.org/10.1007/s00436-005-1363-1] [PMID: 15915364]
[28]
Idris NS, Dwipoerwantoro PG, Kurniawan A, Said M. Intestinal parasitic infection of immunocompromised children with diarrhoea: Clinical profile and therapeutic response. J Infect Dev Ctries 2010; 4(5): 309-17.
[http://dx.doi.org/10.3855/jidc.275] [PMID: 20539063]
[29]
Diaz E, Bernal R, Ramirez E, Mondragon J. Epidemiology and control of intestinal parasites with nitazoxanide in children in Mexico. Am J Trop Med Hyg 2003; 68(4): 384-5.
[http://dx.doi.org/10.4269/ajtmh.2003.68.384] [PMID: 12875284]
[30]
Kick G, Rueff F, Przybilla B. Palmoplantar pruritus subsiding after Blastocystis hominis eradication. Acta Derm Venereol 2002; 82(1): 60.
[http://dx.doi.org/10.1080/000155502753600948] [PMID: 12013204]
[31]
van Hellemond JJ, Molhoek N, Wismans PJ, van Genderen PJJ, Koelewijn R. Is paromomycin the drug of choice for eradication of Blastocystis in adults? J Infect Chemother 2013; 19(3): 545-8.
[http://dx.doi.org/10.1007/s10156-012-0496-2] [PMID: 23053509]
[32]
Abd AL-Khaliq IM. Mohammed ST. Efficiency of Saccharomyces boulardii on Blastocystis hominis in laboratory mice. World J Pharm Res 2015; 4(6): 64-73.
[33]
El-Sayed NM. Evaluation the in vitro effects of ethanol extracts of Ocimum basilicum (sweet basil) and Thymus vulgaris (thyme) for anti-Blastocystis hominis activity. J Med Sci 2009; 30(2): 1229-43.
[34]
El Deeb HK, Al Khadrawy FM, El-Hameid AKA. Inhibitory effect of Ferula asafoetida L. (Umbelliferae) on Blastocystis sp. subtype 3 growth in vitro. Parasitol Res 2012; 111(3): 1213-21.
[http://dx.doi.org/10.1007/s00436-012-2955-1] [PMID: 22584378]
[35]
Abdel-Hafeez EH, Ahmad AK, Kamal AM, Abdellatif MZM, Abdelgelil NH. In vivo antiprotozoan effects of garlic (Allium sativum) and ginger (Zingiber officinale) extracts on experimentally infected mice with Blastocystis spp. Parasitol Res 2015; 114(9): 3439-44.
[http://dx.doi.org/10.1007/s00436-015-4569-x] [PMID: 26085068]
[36]
Abdel-Hafeez E, Ahmad A, Abdelgelil N, Abdellatif M, Kamal A, Mohamed R. In vitro effect of some Egyptian herbal extracts against Blastocystis hominis. J Egypt Soc Parasitol 2015; 45(1): 93-100. [b
[http://dx.doi.org/10.21608/jesp.2015.89700] [PMID: 26012223]
[37]
Abdel Hafeez EH, Ahmed AK, Abdellatif MZM, Kamal AM, Toni MDM. The Efficacy of pomegranate (Punica granatum) peel extract on experimentally infected rats with Blastocystis spp. J Infect Dis Prev Med 2016; 4(1): 131.
[http://dx.doi.org/10.4172/2329-8731.1000131]
[38]
Eida OM, El-Shafei HA, Nomeir YA, El Safhi MB. In vivo and in vitro efficacy of Nigella sativa aqueous extract on Blastocystis hominis. J Egypt Soc Parasitol 2016; 46(1): 27-34.
[http://dx.doi.org/10.12816/0026147] [PMID: 27363038]
[39]
El-Sayed SH, Amer N, Ismail S, et al. In vitro and in vivo anti-Blastocystis efficacy of olive leaf extract and bee pollen compound. J Parasitol 2017; 12(2): 33-44.
[http://dx.doi.org/10.3923/jp.2017.33.44]
[40]
Méabed EMH. El- Sayed NM, Abou-Sreea AIB, Roby MHH. Chemical analysis of aqueous extracts of Origanum majorana and Foeniculum vulgare and their efficacy on Blastocystis spp. cysts. Phytomedicine 2018; 43: 158-63.
[http://dx.doi.org/10.1016/j.phymed.2018.04.017] [PMID: 29747749]
[41]
Ezz Eldin H. Potent lethal effect of Syzygium aromaticum essential oil on Blastocystis spp.: An in vitro study. Parasitol United J 2019; 12(1): 61-7.
[http://dx.doi.org/10.21608/puj.2019.10650.1035]
[42]
Mokhtar AB, Ahmed SA, Eltamany EE, Karanis P. Anti-Blastocystis activity in vitro of Egyptian herbal extracts (family: Asteraceae) with emphasis on Artemisia judaica. Int J Environ Res Public Health 2019; 16(9): 1555.
[http://dx.doi.org/10.3390/ijerph16091555] [PMID: 31058875]
[43]
Riaz H, Begum A, Raza SA, Khan ZMUD, Yousaf H, Tariq A. Antimicrobial property and phytochemical study of ginger found in local area of Punjab, Pakistan. Int Curr Pharm J 2015; 4(7): 405-9.
[http://dx.doi.org/10.3329/icpj.v4i7.23591]
[44]
Wink M. Medicinal plants: A source of anti-parasitic secondary metabolites. Molecules 2012; 17(11): 12771-91.
[http://dx.doi.org/10.3390/molecules171112771] [PMID: 23114614]
[45]
Yang LQ, Singh M, Yap EH, Ng GC, Xu HX, Sim KY. In vitro response of Blastocystis hominis against traditional Chinese medicine. J Ethnopharmacol 1996; 55(1): 35-42.
[http://dx.doi.org/10.1016/S0378-8741(96)01471-7] [PMID: 9121165]
[46]
Vital PG, Rivera WL. Antimicrobial activity and cytotoxicity of Chromolaena odorata (L. f.) King and Robinson and Uncaria perrottetii (A. Rich) Merr. extracts. J Med Plants Res 2009; 3(7): 511-8.
[47]
Force M, Sparks WS, Ronzio RA. Inhibition of enteric parasites by emulsified oil of oregano in vivo. Phytother Res 2000; 14(3): 213-4.
[http://dx.doi.org/10.1002/(SICI)1099-1573(200005)14:3<213:AID-PTR583>3.0.CO;2-U] [PMID: 10815019]
[48]
Özbílgín A. Durmuşkahya C, Kílímcíoğlu AA, et al. In vitro efficacy of Quercus infectoria Oliv. and Achillea millefolium L. extracts against Blastocystis spp. isolates. Kafkas Univ Vet Fak Derg 2013; 19(3): 511-6.
[49]
Bremer Christensen C, Soelberg J, Stensvold CR, Jäger AK. Activity of medicinal plants from Ghana against the parasitic gut protist Blastocystis. J Ethnopharmacol 2015; 174: 569-75.
[http://dx.doi.org/10.1016/j.jep.2015.03.006] [PMID: 25773490]
[50]
Sawangjaroen N, Sawangjaroen K. The effects of extracts from anti-diarrheic Thai medicinal plants on the in vitro growth of the intestinal protozoa parasite: Blastocystis hominis. J Ethnopharmacol 2005; 98(1-2): 67-72.
[http://dx.doi.org/10.1016/j.jep.2004.12.024] [PMID: 15763365]
[51]
Grabensteiner E, Liebhart D, Arshad N, Hess M. Antiprotozoal activities determined in vitro and in vivo of certain plant extracts against Histomonas meleagridis, Tetratrichomonas gallinarum and Blastocystis sp. Parasitol Res 2008; 103(6): 1257-64.
[http://dx.doi.org/10.1007/s00436-008-1122-1] [PMID: 18751730]
[52]
Sánchez ME, Turina AV, García DA, Verónica Nolan M, Perillo MA. Surface activity of thymol: Implications for an eventual pharmacological activity. Colloids Surf B Biointerfaces 2004; 34(2): 77-86.
[http://dx.doi.org/10.1016/j.colsurfb.2003.11.007] [PMID: 15261077]
[53]
de Almeida I, Alviano DS, Vieira DP, et al. Antigiardial activity of Ocimum basilicum essential oil. Parasitol Res 2007; 101(2): 443-52.
[http://dx.doi.org/10.1007/s00436-007-0502-2] [PMID: 17342533]
[54]
Al-Mohammed HI, Hussein EM, Aboulmagd E. Effect of green tea extract and cysteine proteases inhibitor (E-64) on symptomatic genotypes of Blastocystis hominis in vitro and in infected animal model. Int J Curr Microbiol Appl Sci 2013; 2(12): 228-39.
[55]
Tobi SE, Gilbert M, Paul N, McMillan TJ. The green tea polyphenol, epigallocatechin-3-gallate, protects against the oxidative cellular and genotoxic damage of UVA radiation. Int J Cancer 2002; 102(5): 439-44.
[http://dx.doi.org/10.1002/ijc.10730] [PMID: 12432544]
[56]
Lee JH, Shim JS, Chung MS, Lim ST, Kim KH. In vitro anti-adhesive activity of green tea extract against pathogen adhesion. Phytother Res 2009; 23(4): 460-6.
[http://dx.doi.org/10.1002/ptr.2609] [PMID: 19107860]
[57]
Monobe M, Ema K, Tokuda Y, Maeda-Yamamoto M. Effect on the epigallocatechingallate/epigallocat echin ratio in a green tea extract of different extraction temperatures and its effect on IgA production in mice. Biosci Biotechnol Biochem 2010; 74: 2501-3.
[http://dx.doi.org/10.1271/bbb.100498] [PMID: 21150115]
[58]
Puthia MK, Sio SWS, Lu J, Tan KSW. Blastocystis ratti induces contact-independent apoptosis, F-actin rearrangement, and barrier function disruption in IEC-6 cells. Infect Immun 2006; 74(7): 4114-23.
[http://dx.doi.org/10.1128/IAI.00328-06] [PMID: 16790785]
[59]
Girish S, Kumar S, Aminudin N. Tongkat Ali (Eurycoma longifolia): A possible therapeutic candidate against Blastocystis sp. Parasit Vectors 2015; 8(1): 332.
[http://dx.doi.org/10.1186/s13071-015-0942-y] [PMID: 26082155]
[60]
Kuo PC, Shi LS, Damu AG, et al. Cytotoxic and antimalarial beta-carboline alkaloids from the roots of Eurycoma longifolia. J Nat Prod 2003; 66(10): 1324-7.
[http://dx.doi.org/10.1021/np030277n] [PMID: 14575431]
[61]
Yakoob J, Abbas Z, Beg MA, et al. In vitro sensitivity of Blastocystis hominis to garlic, ginger, white cumin, and black pepper used in diet. Parasitol Res 2011; 109(2): 379-85.
[http://dx.doi.org/10.1007/s00436-011-2265-z] [PMID: 21431384]
[62]
El-Sayed NM. Efficacy of Zingiber officinale ethanol extract on the viability, embryogenesis and infectivity of Toxocara canis eggs. J Parasit Dis 2017; 41(4): 1020-7.
[http://dx.doi.org/10.1007/s12639-017-0928-0] [PMID: 29114136]
[63]
Kniel K, Sumner SS, Lindsay DS, et al. Effect of organic acids and hydrogen peroxide on Cryptosporidium parvum viability in fruit juices. J Food Prot 2003; 66(9): 1650-7.
[http://dx.doi.org/10.4315/0362-028X-66.9.1650] [PMID: 14503720]
[64]
Choi JG, Kang OH, Lee YS, et al. In vitro and in vivo antibacterial activity of Punica granatum peel ethanol extract against Salmonella. Evid Based Complement Alternat Med 2011; 2011: 1-8.
[http://dx.doi.org/10.1093/ecam/nep105] [PMID: 19687188]
[65]
Haris Omar S. Oleuropein in olive and its pharmacological effects. Sci Pharm 2010; 78(2): 133-54.
[http://dx.doi.org/10.3797/scipharm.0912-18] [PMID: 21179340]
[66]
Jiang JH, Jin CM, Kim YC, Kim HS, Park WC, Park H. Anti-toxoplasmosis effects of oleuropein isolated from Fraxinus rhychophylla. Biol Pharm Bull 2008; 31(12): 2273-6.
[http://dx.doi.org/10.1248/bpb.31.2273] [PMID: 19043212]
[67]
Roby MHH, Sarhan MA, Selim KAH, Khalel KI. Evaluation of antioxidant activity, total phenols and phenolic compounds in thyme (Thymus vulgaris L.), sage (Salvia officinalis L.), and marjoram (Origanum majorana L.) extracts. Ind Crops Prod 2013; 43: 827-31. [a
[http://dx.doi.org/10.1016/j.indcrop.2012.08.029]
[68]
Roby MHH, Sarhan MA, Selim KAH, Khalel KI. Antioxidant and antimicrobial activities of essential oil and extracts of fennel (Foeniculum vulgare L.) and chamomile (Matricaria chamomilla L.). Ind Crops Prod 2013; 44: 437-45. [b
[http://dx.doi.org/10.1016/j.indcrop.2012.10.012]
[69]
Bakr R. Microscopical and phytochemical investigation of Egyptian Artemisia judaica l. Var. Sinaitica tackholm and its free radical scavenging activity. Int J Pharmacogn Phytochem Res 2015; 6: 698-703.
[70]
Wu B, Yin J, Texier C, Roussel M, Tan KSW. Blastocystis legumain is localized on the cell surface, and specific inhibition of its activity implicates a pro-survival role for the enzyme. J Biol Chem 2010; 285(3): 1790-8.
[http://dx.doi.org/10.1074/jbc.M109.049064] [PMID: 19915007]
[71]
Latifah-Munirah B, Himratul-Aznita WH, Mohd Zain N. Eugenol, an essential oil of clove, causes disruption to the cell wall of Candida albicans (ATCC 14053). Front Life Sci 2015; 8(3): 231-40.
[http://dx.doi.org/10.1080/21553769.2015.1045628]
[72]
Qadir M, Fatima K. Review on the pharmacological activity of amygdalin. Arch Cancer Res 2017; 5(4): 160.
[http://dx.doi.org/10.21767/2254-6081.100160]
[73]
Yadav M, Jain S, Tomar R, Prasad GBKS, Yadav H. Medicinal and biological potential of pumpkin: An updated review. Nutr Res Rev 2010; 23(2): 184-90.
[http://dx.doi.org/10.1017/S0954422410000107] [PMID: 21110905]
[74]
Salman SS, Ardalan NM. Evaluation of Amygdalin (B17) and Cucurbita pepo (Pumpkin seed) activity against Blastocystis from diarrheic patients in Baghdad, Iraq: In vitro study. Baghdad Sci J 2022; 19(1): 16-25.

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy